应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NVS 诺华
休市中 08-15 16:00:00 EDT
124.21
+2.12
+1.74%
盘后
124.00
-0.21
-0.17%
19:33 EDT
最高
124.31
最低
122.56
成交量
117.88万
今开
122.66
昨收
122.09
日振幅
1.43%
总市值
2,405亿
流通市值
2,290亿
总股本
19.36亿
成交额
1.46亿
换手率
0.06%
流通股本
18.44亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
8月13日诺华通过其微信公众号宣布ianalumab(VAY736)用于活动性干燥综合征成人患者的III期临床试验取得积
智通财经 · 08-13 12:22
8月13日诺华通过其微信公众号宣布ianalumab(VAY736)用于活动性干燥综合征成人患者的III期临床试验取得积
诺华制药8月11日成交额为3.09亿美元
市场透视 · 08-12
诺华制药8月11日成交额为3.09亿美元
诺华制药(NVS.US)抗BAFF-R单抗两项III期研究成功
智通财经 · 08-11
诺华制药(NVS.US)抗BAFF-R单抗两项III期研究成功
诺华称Ianalumab第三阶段试验达成主要终点。
智通财经 · 08-11
诺华称Ianalumab第三阶段试验达成主要终点。
诺华制药8月8日成交额为1.85亿美元
市场透视 · 08-09
诺华制药8月8日成交额为1.85亿美元
诺华制药8月7日成交额为1.53亿美元
市场透视 · 08-08
诺华制药8月7日成交额为1.53亿美元
诺华制药8月6日成交额为2.30亿美元
市场透视 · 08-07
诺华制药8月6日成交额为2.30亿美元
诺华考虑收购生物技术公司Avidity Biosciences
环球市场播报 · 08-06
诺华考虑收购生物技术公司Avidity Biosciences
诺华制药拟收购Avidity Biosciences扩充医药管线
DoNews · 08-06
诺华制药拟收购Avidity Biosciences扩充医药管线
有报道称瑞士诺华公司考虑收购艾维迪蒂公司(Avidity)后该公司股价上涨18%。
智通财经 · 08-06
有报道称瑞士诺华公司考虑收购艾维迪蒂公司(Avidity)后该公司股价上涨18%。
诺华制药据悉提议收购Avidity Biosciences Inc.,考虑扩充医药管线。
格隆汇 · 08-06
诺华制药据悉提议收购Avidity Biosciences Inc.,考虑扩充医药管线。
医疗保健类股正成为欧洲股市的拖累一系列不同风险已体现在其股价估值中且这类股票正变得愈发便宜。该板块对斯托克 600 指数
智通财经 · 08-06
医疗保健类股正成为欧洲股市的拖累一系列不同风险已体现在其股价估值中且这类股票正变得愈发便宜。该板块对斯托克 600 指数
诺华制药8月5日成交额为1.71亿美元
市场透视 · 08-06
诺华制药8月5日成交额为1.71亿美元
诺华(NVS.US)“一年两针”长效降脂药启动新III期临床
智通财经 · 08-05
诺华(NVS.US)“一年两针”长效降脂药启动新III期临床
诺华制药8月4日成交额为2.80亿美元
市场透视 · 08-05
诺华制药8月4日成交额为2.80亿美元
在美国就药品价格问题致函医药企业后诺华制药股价在欧盘下跌1.2%;罗氏股价下跌1.9%。
智通财经 · 08-04
在美国就药品价格问题致函医药企业后诺华制药股价在欧盘下跌1.2%;罗氏股价下跌1.9%。
诺华制药8月1日成交额为2.21亿美元
市场透视 · 08-02
诺华制药8月1日成交额为2.21亿美元
诺华制药7月31日成交额为2.07亿美元
市场透视 · 08-01
诺华制药7月31日成交额为2.07亿美元
诺华(NVS.US)siRNA疗法Leqvio再获FDA批准用于降低LDL-C
智通财经 · 08-01
诺华(NVS.US)siRNA疗法Leqvio再获FDA批准用于降低LDL-C
诺华(NVS.US)siRNA疗法Leqvio再获FDA批准用于降低LDL-C
智通财经 · 08-01
诺华(NVS.US)siRNA疗法Leqvio再获FDA批准用于降低LDL-C
加载更多
公司概况
公司名称:
诺华
所属市场:
NYSE
上市日期:
--
主营业务:
Novartis AG于1996年2月29日在瑞士成立。该公司是一家创新药物公司,从事各种创新药物的研究、开发、制造、分销、营销和销售。该公司的宗旨是利用其科学专业知识寻找治疗和治愈疾病的新方法,重新构想医学,以改善和延长人们的生命。该公司的业务分为五个组织部门:生物医学研究、开发、运营和两个商业部门(美国和国际)。全球职能部门支持这些组织部门开展工作。该公司专注于四个具有强大增长潜力和大量未满足患者需求的核心治疗领域—心血管、肾脏和代谢;免疫学;神经科学;和肿瘤学。
发行价格:
--
{"stockData":{"symbol":"NVS","market":"US","secType":"STK","nameCN":"诺华","latestPrice":124.21,"timestamp":1755288000000,"preClose":122.09,"halted":0,"volume":1178830,"hourTrading":{"tag":"盘后","latestPrice":124,"preClose":124.21,"latestTime":"19:33 EDT","volume":40093,"amount":4979824.83,"timestamp":1755300788908},"delay":0,"floatShares":1843882545,"shares":1935853188,"eps":6.849934,"marketStatus":"休市中","change":2.12,"latestTime":"08-15 16:00:00 EDT","open":122.655,"high":124.31,"low":122.56,"amount":145899993.2674,"amplitude":0.014334,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.849934,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1755504000000},"marketStatusCode":7,"adr":1,"adrRate":1,"exchange":"NYSE","adjPreClose":122.09,"dividendRate":0.031095,"preHourTrading":{"tag":"盘前","latestPrice":122.62,"preClose":122.155,"latestTime":"09:29 EDT","volume":2926,"amount":358835.45236,"timestamp":1755264599999},"postHourTrading":{"tag":"盘后","latestPrice":124,"preClose":124.21,"latestTime":"19:33 EDT","volume":40093,"amount":4979824.83,"timestamp":1755300788908},"volumeRatio":0.7687435711481344,"impliedVol":0.2213,"impliedVolPercentile":0.292},"requestUrl":"/m/hq/s/NVS","defaultTab":"news","newsList":[{"id":"2559604208","title":"8月13日诺华通过其微信公众号宣布ianalumab(VAY736)用于活动性干燥综合征成人患者的III期临床试验取得积","url":"https://stock-news.laohu8.com/highlight/detail?id=2559604208","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559604208?lang=zh_cn&edition=full","pubTime":"2025-08-13 20:22","pubTimestamp":1755087727,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0208291251.USD","BK4007","BK4585","IE00BJT1NW94.SGD","BK4578","IE00BJJMRZ35.SGD","III","BK4134","IE0009355771.USD","BK4588","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BK4532","LU0211331839.USD","LU0320765489.SGD","IE0002141913.USD","NVS","LU0070302665.USD"],"gpt_icon":0},{"id":"2558131046","title":"诺华制药8月11日成交额为3.09亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558131046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558131046?lang=zh_cn&edition=full","pubTime":"2025-08-12 12:51","pubTimestamp":1754974288,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日,诺华制药成交额为3.09亿美元,成交额较昨日增加67.18%,当日成交量为261.26万股。诺华制药于2025年8月11日涨1.46%,报118.55美元,该股过去5个交易日涨0.61%,年初至今涨27.04%,过去60日涨12.92%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-08-11|3.09亿|67.18%|261.26万|#|2025-08-08|1.85亿|20.79%|158.50万|#|2025-08-07|1.53亿|-33.53%|132.67万|#|2025-08-06|2.30亿|34.83%|201.67万|#|2025-08-05|1.71亿|-39.01%|144.73万|诺华开发和生产创新药物。该公司的产品销往全球,其中美国占总收入的近三分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812125133a483471a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812125133a483471a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765489.SGD","BK4585","BK4578","IE00B4R5TH58.HKD","IE0009355771.USD","IE00B2B36J28.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","NVS","LU0208291251.USD","LU0070302665.USD","LU0211331839.USD","BK4007","BK4532","BK4588","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2558346496","title":"诺华制药(NVS.US)抗BAFF-R单抗两项III期研究成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2558346496","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558346496?lang=zh_cn&edition=full","pubTime":"2025-08-11 14:56","pubTimestamp":1754895391,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,8月11日,诺华制药(NVS.US)宣布Ianalumab(VAY736)治疗活动性干燥综合征的两项III期研究(NEPTUNUS-1和NEPTUNUS-2)取得了积极结果。该药物有望成为干燥综合征领域首个靶向治疗药物。Ianalumab是诺华收购(MorphoSys)获得的一款靶向B淋巴细胞活化因子受体(BAFF-R)的全人源单抗,具有耗竭B细胞和抑制BAFF-R的双重作用机制,可用于治疗干燥综合征、免疫性血小板减少症(ITP)、系统性红斑狼疮(SLE)等多种自免疾病。该药物是首个完成III期研究的抗BAFF-R抗体。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1327927.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0002141913.USD","LU0070302665.USD","IE00BFTCPJ56.SGD","01477","BK1191","LU0208291251.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0320765489.SGD","BK4585","BK4588","BK4134","BK4007","BK4532","BK4578","BK1574","LU0211331839.USD","NVS","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","III"],"gpt_icon":0},{"id":"2558639650","title":"诺华称Ianalumab第三阶段试验达成主要终点。","url":"https://stock-news.laohu8.com/highlight/detail?id=2558639650","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558639650?lang=zh_cn&edition=full","pubTime":"2025-08-11 13:28","pubTimestamp":1754890135,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BJT1NW94.SGD","LU0208291251.USD","LU0211331839.USD","NVS","IE00B2B36J28.USD","BK4588","BK4532","BK4585","IE00BFTCPJ56.SGD","LU0070302665.USD","BK4007","LU0320765489.SGD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE0009355771.USD","BK4578"],"gpt_icon":0},{"id":"2558506877","title":"诺华制药8月8日成交额为1.85亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558506877","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558506877?lang=zh_cn&edition=full","pubTime":"2025-08-09 12:51","pubTimestamp":1754715063,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日,诺华制药成交额为1.85亿美元,成交额较昨日增加20.79%,当日成交量为158.50万股。诺华制药于2025年8月8日涨0.79%,报116.84美元,该股过去5个交易日涨1.34%,年初至今涨25.21%,过去60日涨9.37%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-08-08|1.85亿|20.79%|158.50万|#|2025-08-07|1.53亿|-33.53%|132.67万|#|2025-08-06|2.30亿|34.83%|201.67万|#|2025-08-05|1.71亿|-39.01%|144.73万|#|2025-08-04|2.80亿|26.61%|238.97万|诺华开发和生产创新药物。该公司的产品销往全球,其中美国占总收入的近三分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809125109a6dc188f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809125109a6dc188f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765489.SGD","BK4585","BK4578","IE00B4R5TH58.HKD","IE0009355771.USD","IE00B2B36J28.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","NVS","LU0208291251.USD","LU0070302665.USD","LU0211331839.USD","BK4007","BK4532","BK4588","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2557512288","title":"诺华制药8月7日成交额为1.53亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557512288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557512288?lang=zh_cn&edition=full","pubTime":"2025-08-08 12:48","pubTimestamp":1754628510,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日,诺华制药成交额为1.53亿美元,成交额较昨日减少33.53%,当日成交量为132.67万股。诺华制药于2025年8月7日涨2.13%,报115.92美元,该股过去5个交易日涨1.92%,年初至今涨24.22%,过去60日涨6.4%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-08-07|1.53亿|-33.53%|132.67万|#|2025-08-06|2.30亿|34.83%|201.67万|#|2025-08-05|1.71亿|-39.01%|144.73万|#|2025-08-04|2.80亿|26.61%|238.97万|#|2025-08-01|2.21亿|6.71%|192.80万|诺华开发和生产创新药物。该公司的产品销往全球,其中美国占总收入的近三分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808124833a47c62c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808124833a47c62c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765489.SGD","BK4585","BK4578","IE00B4R5TH58.HKD","IE0009355771.USD","IE00B2B36J28.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","NVS","LU0208291251.USD","LU0070302665.USD","LU0211331839.USD","BK4007","BK4532","BK4588","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2557953529","title":"诺华制药8月6日成交额为2.30亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557953529","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557953529?lang=zh_cn&edition=full","pubTime":"2025-08-07 12:43","pubTimestamp":1754541803,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日,诺华制药成交额为2.30亿美元,成交额较昨日增加34.83%,当日成交量为201.67万股。诺华制药于2025年8月6日跌3.59%,报113.5美元,该股过去5个交易日跌2.68%,年初至今涨21.63%,过去60日涨4.42%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-08-06|2.30亿|34.83%|201.67万|#|2025-08-05|1.71亿|-39.01%|144.73万|#|2025-08-04|2.80亿|26.61%|238.97万|#|2025-08-01|2.21亿|6.71%|192.80万|#|2025-07-31|2.07亿|25.16%|180.33万|诺华开发和生产创新药物。该公司的产品销往全球,其中美国占总收入的近三分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807124324a47a16f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807124324a47a16f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B4R5TH58.HKD","BK4007","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0211331839.USD","NVS","BK4588","BK4578","BK4585","IE00BJT1NW94.SGD","LU0208291251.USD","LU0070302665.USD","LU0320765489.SGD","BK4532","IE0002141913.USD","IE0009355771.USD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2557062683","title":"诺华考虑收购生物技术公司Avidity Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2557062683","media":"环球市场播报","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557062683?lang=zh_cn&edition=full","pubTime":"2025-08-07 00:24","pubTimestamp":1754497495,"startTime":"0","endTime":"0","summary":"英国《金融时报》援引知情人士的话报道,瑞士制药商诺华已与美国生物技术公司 Avidity Biosciences 接触,可能提出收购要约。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:郭明煜","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-08-07/doc-infkaqmn6370713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["IE00B2B36J28.USD","LU0211331839.USD","IE00BJT1NW94.SGD","BK4578","BK4532","LU0208291251.USD","BK4585","LU0320765489.SGD","BK4139","NVS","BK4588","BK4505","LU0070302665.USD","IE0009355771.USD","RNA","IE00B4R5TH58.HKD","BK4007","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2557350306","title":"诺华制药拟收购Avidity Biosciences扩充医药管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2557350306","media":"DoNews","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557350306?lang=zh_cn&edition=full","pubTime":"2025-08-06 23:53","pubTimestamp":1754495582,"startTime":"0","endTime":"0","summary":"北京时间2025年8月6日,诺华制药据悉已提议收购生物技术公司Avidity Biosciences Inc.,旨在扩充其医药研发管线。此次收购若达成,将有助于诺华在创新疗法领域的进一步布局。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508062355199737c073&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508062355199737c073&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0211331839.USD","BK4007","IE00BFTCPJ56.SGD","LU0070302665.USD","IE00B2B36J28.USD","NVS","IE0009355771.USD","IE00B4R5TH58.HKD","BK4139","BK4578","LU0208291251.USD","LU0320765489.SGD","RNA","IE0002141913.USD","BK4532","BK4505","BK4585","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2557730595","title":"有报道称瑞士诺华公司考虑收购艾维迪蒂公司(Avidity)后该公司股价上涨18%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2557730595","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557730595?lang=zh_cn&edition=full","pubTime":"2025-08-06 23:22","pubTimestamp":1754493739,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0070302665.USD","IE0002141913.USD","IE00B2B36J28.USD","BK4585","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0211331839.USD","NVS","BK4532","BK4007","BK4578","IE0009355771.USD","IE00B4R5TH58.HKD","LU0208291251.USD","LU0320765489.SGD","BK4588"],"gpt_icon":0},{"id":"2557602305","title":"诺华制药据悉提议收购Avidity Biosciences Inc.,考虑扩充医药管线。","url":"https://stock-news.laohu8.com/highlight/detail?id=2557602305","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557602305?lang=zh_cn&edition=full","pubTime":"2025-08-06 23:21","pubTimestamp":1754493662,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1574","IE00BJJMRZ35.SGD","BK4585","IE00BFTCPJ56.SGD","09939","NVS","IE00B2B36J28.USD","BK4007","IE00B4R5TH58.HKD","LU0211331839.USD","01477","BK4578","BK4588","BK1161","LU0208291251.USD","LU0320765489.SGD","BK4139","BK1191","159938","BK1515","LU0070302665.USD","IE0002141913.USD","IE0009355771.USD","BK4532","RNA","IE00BJT1NW94.SGD","BK4505"],"gpt_icon":0},{"id":"2557320942","title":"医疗保健类股正成为欧洲股市的拖累一系列不同风险已体现在其股价估值中且这类股票正变得愈发便宜。该板块对斯托克 600 指数","url":"https://stock-news.laohu8.com/highlight/detail?id=2557320942","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557320942?lang=zh_cn&edition=full","pubTime":"2025-08-06 18:10","pubTimestamp":1754475021,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4578","IE00BFTCPJ56.SGD","IE00BZ1G4Q59.USD","LU0070302665.USD","IE0002141913.USD","BK4585","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0320765489.SGD","NVO","LU0154236417.USD","IE00B2B36J28.USD","IE00BKVL7J92.USD","IE0009355771.USD","BK4588","BK4007","159891","LU0211331839.USD","159646","BK4532","NVS","BK4599","IE00BJT1NW94.SGD","LU1093756168.USD","LU1093756325.SGD","LU0208291251.USD"],"gpt_icon":0},{"id":"2557347837","title":"诺华制药8月5日成交额为1.71亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557347837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557347837?lang=zh_cn&edition=full","pubTime":"2025-08-06 12:36","pubTimestamp":1754455014,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日,诺华制药成交额为1.71亿美元,成交额较昨日减少39.01%,当日成交量为144.73万股。诺华制药于2025年8月5日跌0.08%,报117.73美元,该股过去5个交易日涨0.44%,年初至今涨26.16%,过去60日涨6.9%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-08-05|1.71亿|-39.01%|144.73万|#|2025-08-04|2.80亿|26.61%|238.97万|#|2025-08-01|2.21亿|6.71%|192.80万|#|2025-07-31|2.07亿|25.16%|180.33万|#|2025-07-30|1.65亿|-2.54%|141.51万|诺华开发和生产创新药物。该公司的产品销往全球,其中美国占总收入的近三分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806123659a6d5c810&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806123659a6d5c810&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4578","IE00BJT1NW94.SGD","BK4585","IE00B4R5TH58.HKD","LU0211331839.USD","IE0002141913.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0320765489.SGD","NVS","BK4588","LU0208291251.USD","BK4532","BK4007","LU0070302665.USD","IE0009355771.USD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2557394195","title":"诺华(NVS.US)“一年两针”长效降脂药启动新III期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2557394195","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557394195?lang=zh_cn&edition=full","pubTime":"2025-08-05 20:57","pubTimestamp":1754398648,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,8 月 4 日,ClinicalTrials.gov 官网显示,诺华登记了一项英克司兰钠的 III 期临床,旨在评估急性冠状动脉综合征患者住院早期开始英克司兰钠治疗的疗效和安全性。英克司兰钠是全球首款获批的 PCSK9 siRNA 药物,于 2020 年、2021 年分别获欧盟、FDA 批准上市,用于治疗成人高胆固醇血症及混合性血脂异常,证明了小核酸药物在慢病领域的治疗潜力。截至目前,该药已经在欧盟获批 4 项适应症,在美国获批 3 项适应症,在中国获批 4 项适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1326021.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0211331839.USD","IE00BJJMRZ35.SGD","BK4134","IE00BJT1NW94.SGD","BK4532","NVS","LU0208291251.USD","BK4585","IE00B2B36J28.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","III","LU0070302665.USD","IE0009355771.USD","IE00B4R5TH58.HKD","BK4578","BK4007","IE0002141913.USD","BK4588"],"gpt_icon":0},{"id":"2557354460","title":"诺华制药8月4日成交额为2.80亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557354460","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557354460?lang=zh_cn&edition=full","pubTime":"2025-08-05 12:36","pubTimestamp":1754368599,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日,诺华制药成交额为2.80亿美元,成交额较昨日增加26.61%,当日成交量为238.97万股。诺华制药于2025年8月4日涨2.19%,报117.83美元,该股过去5个交易日涨1.42%,年初至今涨26.27%,过去60日涨5.49%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-08-04|2.80亿|26.61%|238.97万|#|2025-08-01|2.21亿|6.71%|192.80万|#|2025-07-31|2.07亿|25.16%|180.33万|#|2025-07-30|1.65亿|-2.54%|141.51万|#|2025-07-29|1.70亿|-15.20%|144.91万|诺华开发和生产创新药物。该公司的产品销往全球,其中美国占总收入的近三分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805123640a6d3b26d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805123640a6d3b26d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0208291251.USD","LU0320765489.SGD","BK4007","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE0002141913.USD","BK4578","BK4585","LU0211331839.USD","NVS","LU0070302665.USD","IE00BFTCPJ56.SGD","BK4532","IE0009355771.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BK4588"],"gpt_icon":0},{"id":"2556816805","title":"在美国就药品价格问题致函医药企业后诺华制药股价在欧盘下跌1.2%;罗氏股价下跌1.9%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2556816805","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556816805?lang=zh_cn&edition=full","pubTime":"2025-08-04 15:09","pubTimestamp":1754291372,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE0009355771.USD","IE0002141913.USD","NVS","BK4585","BK4578","LU0320765489.SGD","BK4588","IE00B4R5TH58.HKD","01477","IE00BFTCPJ56.SGD","LU0208291251.USD","IE00BJT1NW94.SGD","BK4007","BK1191","BK1574","IE00B2B36J28.USD","LU0211331839.USD","BK4532","LU0070302665.USD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2556847718","title":"诺华制药8月1日成交额为2.21亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556847718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556847718?lang=zh_cn&edition=full","pubTime":"2025-08-02 12:43","pubTimestamp":1754109811,"startTime":"0","endTime":"0","summary":"美东时间2025年8月1日,诺华制药成交额为2.21亿美元,成交额较昨日增加6.71%,当日成交量为192.80万股。诺华制药于2025年8月1日涨1.37%,报115.3美元,该股过去5个交易日跌2.04%,年初至今涨23.56%,过去60日涨4.3%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-08-01|2.21亿|6.71%|192.80万|#|2025-07-31|2.07亿|25.16%|180.33万|#|2025-07-30|1.65亿|-2.54%|141.51万|#|2025-07-29|1.70亿|-15.20%|144.91万|#|2025-07-28|2.00亿|-30.37%|172.06万|诺华开发和生产创新药物。该公司的产品销往全球,其中美国占总收入的近三分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802124332a6ced8a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802124332a6ced8a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B2B36J28.USD","LU0211331839.USD","NVS","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0320765489.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4585","LU0070302665.USD","IE00BJT1NW94.SGD","BK4578","BK4588","BK4007","LU0208291251.USD","BK4532","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2556869500","title":"诺华制药7月31日成交额为2.07亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556869500","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556869500?lang=zh_cn&edition=full","pubTime":"2025-08-01 12:40","pubTimestamp":1754023211,"startTime":"0","endTime":"0","summary":"美东时间2025年7月31日,诺华制药成交额为2.07亿美元,成交额较昨日增加25.16%,当日成交量为180.33万股。诺华制药于2025年7月31日跌2.48%,报113.74美元,该股过去5个交易日跌3.17%,年初至今涨21.89%,过去60日涨0.58%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-31|2.07亿|25.16%|180.33万|#|2025-07-30|1.65亿|-2.54%|141.51万|#|2025-07-29|1.70亿|-15.20%|144.91万|#|2025-07-28|2.00亿|-30.37%|172.06万|#|2025-07-25|2.88亿|5.83%|245.60万|诺华开发和生产创新药物。该公司的产品销往全球,其中美国占总收入的近三分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801124019a6ccfa21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801124019a6ccfa21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0208291251.USD","BK4578","LU0320765489.SGD","LU0211331839.USD","IE0002141913.USD","BK4585","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0070302665.USD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4007","IE00B2B36J28.USD","BK4532","BK4588","NVS"],"gpt_icon":0},{"id":"2556571588","title":"诺华(NVS.US)siRNA疗法Leqvio再获FDA批准用于降低LDL-C","url":"https://stock-news.laohu8.com/highlight/detail?id=2556571588","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556571588?lang=zh_cn&edition=full","pubTime":"2025-08-01 09:08","pubTimestamp":1754010482,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B2B36J28.USD","LDL","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0070302665.USD","BK4588","NVS","IE00BJT1NW94.SGD","RNA","IE0009355771.USD","LU0208291251.USD","LU0320765489.SGD","LU0211331839.USD","BK4585","BK4505","IE00B4R5TH58.HKD","BK4007","BK4139","BK4532","BK4578","IE0002141913.USD"],"gpt_icon":0},{"id":"2556130857","title":"诺华(NVS.US)siRNA疗法Leqvio再获FDA批准用于降低LDL-C","url":"https://stock-news.laohu8.com/highlight/detail?id=2556130857","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556130857?lang=zh_cn&edition=full","pubTime":"2025-08-01 09:08","pubTimestamp":1754010482,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,江苏诺华公司今日宣布,美国FDA已批准其每年两次给药的小干扰RNA疗法Leqvio的扩展适应症申请,允许其作为单药,与饮食控制和运动联合使用,以降低成人高胆固醇血症患者的低密度脂蛋白胆固醇水平。Leqvio是一款“first-in-class”、靶向PCSK9 mRNA的siRNA疗法,最初于2021年12月获得美国FDA批准,作为饮食和他汀类药物治疗的辅助药物,用于治疗患有原发性高脂血症的成年患者,包括杂合子型家族性高胆固醇血症患者,以降低其LDL-C的水平。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1324584.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0208291251.USD","LU0320765489.SGD","LU0211331839.USD","IE00B2B36J28.USD","BK4532","BK4578","BK4588","BK4585","LDL","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","NVS","IE0002141913.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BK4007","IE0009355771.USD","LU0070302665.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novartis.com","stockEarnings":[{"period":"1week","weight":0.0631},{"period":"1month","weight":0.0493},{"period":"3month","weight":0.1334},{"period":"6month","weight":0.1781},{"period":"1year","weight":0.0962},{"period":"ytd","weight":0.2764}],"compareEarnings":[{"period":"1week","weight":0.0098},{"period":"1month","weight":0.0308},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1634},{"period":"ytd","weight":0.0979}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novartis AG于1996年2月29日在瑞士成立。该公司是一家创新药物公司,从事各种创新药物的研究、开发、制造、分销、营销和销售。该公司的宗旨是利用其科学专业知识寻找治疗和治愈疾病的新方法,重新构想医学,以改善和延长人们的生命。该公司的业务分为五个组织部门:生物医学研究、开发、运营和两个商业部门(美国和国际)。全球职能部门支持这些组织部门开展工作。该公司专注于四个具有强大增长潜力和大量未满足患者需求的核心治疗领域—心血管、肾脏和代谢;免疫学;神经科学;和肿瘤学。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.011336},{"month":2,"riseRate":0.44,"avgChangeRate":-0.010046},{"month":3,"riseRate":0.52,"avgChangeRate":0.001443},{"month":4,"riseRate":0.72,"avgChangeRate":0.018717},{"month":5,"riseRate":0.68,"avgChangeRate":0.009252},{"month":6,"riseRate":0.576923,"avgChangeRate":0.011998},{"month":7,"riseRate":0.692308,"avgChangeRate":0.011407},{"month":8,"riseRate":0.423077,"avgChangeRate":0.000361},{"month":9,"riseRate":0.68,"avgChangeRate":0.009526},{"month":10,"riseRate":0.44,"avgChangeRate":-0.01226},{"month":11,"riseRate":0.6,"avgChangeRate":0.014931},{"month":12,"riseRate":0.68,"avgChangeRate":0.019169}],"exchange":"NYSE","name":"诺华","nameEN":"Novartis AG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.8","shortVersion":"4.34.8","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺华(NVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺华(NVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺华,NVS,诺华股票,诺华股票老虎,诺华股票老虎国际,诺华行情,诺华股票行情,诺华股价,诺华股市,诺华股票价格,诺华股票交易,诺华股票购买,诺华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺华(NVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺华(NVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}